AIChE's website is experiencing issues with Login, online registration, join, renew and other transactions. We are working to resolve the problem and apologize for the inconvenience.
Evelyn Eggenstein
Product Development Scientist
Arbor Biosciences
Dr. Evelyn Eggenstein is product development scientist of myTXTL®Cell-Free Protein Expression kits at Arbor Biosciences. In this position, she leads myTXTL®R&D operations, coordinates manufacturing of standard and customized kits, and markets the myTXTL®product line.
Prior to this role, Eggenstein completed her Ph.D. in Prof. Arne Skerra's laboratory at the Technical University Munich, where she focused on the construction of Anticalin®fusion proteins for therapy and diagnostics. She successfully showed that Anticalins®are a promising alternative to antibodies, and bispecific fusion protein thereof are highly suitable for pre-targeted radio-treatment of cancer diseases.
After moving to the Detroit area, Eggenstein pursued her passion for protein science and joined ArborBiosciences to develop and market the all-E. colicell-free platform myTXTL®. This has allowed Arbor Biosciences to become a provider of comprehensive solutions in the synthetic biology market starting from DNA synthesis to protein expression.
Eggenstein holds a patent on a collection of muteins of a1m lipocalin and methodsof their production.
Eggenstein received a B. S. and M. S. in molecular biotechnology from Technical University Munich.